NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors

Lignende værker

• BCR-ABL1 compound mutants display differential and dose-dependent responses to ponatinib
  af: Byrgazov, Konstantin, et al.
  Udgivet: (2018)
• Transposon-mediated generation of BCR-ABL1-expressing transgenic cell lines for unbiased sensitivity testing of tyrosine kinase inhibitors
  af: Byrgazov, Konstantin, et al.
  Udgivet: (2016)
• Cell biology: A key driver of therapeutic innovation
  af: Hantschel, Oliver, et al.
  Udgivet: (2012)
• Granulomatous Amebic Encephalitis in a Child with Acute Lymphoblastic Leukemia Successfully Treated with Multimodal Antimicrobial Therapy and Hyperbaric Oxygen
  af: Maritschnegg, P., et al.
  Udgivet: (2011)
• The Phenotype and Treatment of WIP Deficiency: Literature Synopsis and Review of a Patient With Pre-transplant Serial Donor Lymphocyte Infusions to Eliminate CMV
  af: Schwinger, Wolfgang, et al.
  Udgivet: (2018)